Displaying 1 to 20 of 90 investments
Company | Country | Date | Notes | ||
---|---|---|---|---|---|
Acceleron Pharma Inc Biopharmaceutical company developing protein therapeutics for cancer and orphan diseases. |
United States | 1 Dec 2009 | Series D Follow-on investment. Round participant. Active |
||
Acceleron Pharma Inc Biopharmaceutical company developing protein therapeutics for cancer and orphan diseases. |
United States | 1 Oct 2007 | Series C Follow-on investment. Round participant. Active |
||
Acceleron Pharma Inc Biopharmaceutical company developing protein therapeutics for cancer and orphan diseases. |
United States | 31 Dec 2004 | N/A Initial investment. Round participant. Active |
||
Acceleron Pharma Inc Biopharmaceutical company developing protein therapeutics for cancer and orphan diseases. |
United States | 1 Dec 2011 | Series F Follow-on investment. Round participant. Active |
||
Acceleron Pharma Inc Biopharmaceutical company developing protein therapeutics for cancer and orphan diseases. |
United States | 1 Aug 2006 | Series B Follow-on investment. Round participant. Active |
||
Accuri Cytometers Inc Maker of personal flow cytometers for researchers. |
United States | 31 Dec 2008 | N/A Active |
||
Adolor Corp |
United States | 31 Dec 1996 | N/A Active |
||
Advanced Electron Beams Inc Provider of electron beam energy technology products and solutions worldwide. |
United States | 31 Dec 2009 | N/A Active |
||
Advanced TelCom Inc |
United States | N/A |
|||
Affinity Express Inc |
United States | N/A |
|||
Agios Pharmaceuticals Inc |
United States | 31 Dec 2007 | N/A |
||
Alere Medical Inc A disease management company focused on internet-based medical monitoring systems for patients with chronic diseases. |
United States | 31 Dec 1998 | N/A Active |
||
Alvine Pharmaceuticals Inc An innovative biopharmaceutical company developing biologics to target autoimmune/ inflammatory diseases. |
United States | 31 Dec 2006 | N/A Active |
||
Anesta Corp A pharmaceutical company focused on powerful drug system to control the severe pain of end stage cancer. |
United States | 31 Dec 1986 | N/A Active |
||
Antigenics Inc A biotechnology company focused on technology and products to treat cancers, infectious diseases, and autoimmune disorders. |
United States | 31 Dec 1994 | N/A Initial investment. Round participant. Active |
||
Arbor Networks Inc DDoS attack prevention, network security and visibility solutions company. |
United States | N/A Initial investment. Round participant. Active |
|||
Aspect Medical Systems Inc Provider of of brain monitoring technology solutions. |
United States | 31 Dec 1995 | N/A Active |
||
AudioLogic Inc An audio technology company focused on high performance digital signal processing systems. |
United States | 31 Dec 1993 | N/A Initial investment. Round participant. Active |
||
Avedro Inc A medical device company focused on vision correctional devices and has developed innovative ophthalmology solutions for the Lasik and myopia markets. |
United States | 1 Jul 2011 | Series C Follow-on investment. Round participant. Active |
||
Avedro Inc A medical device company focused on vision correctional devices and has developed innovative ophthalmology solutions for the Lasik and myopia markets. |
United States | 1 May 2009 | Series B Initial investment. Round participant. Active |